2011
Effects of sigma receptor ligands in mammalian myocardium
FIALOVÁ, Kateřina a Marie NOVÁKOVÁZákladní údaje
Originální název
Effects of sigma receptor ligands in mammalian myocardium
Autoři
Vydání
Germany, 156 s. 2011
Nakladatel
LAP LAMBERT Academic Publishing
Další údaje
Jazyk
angličtina
Typ výsledku
Odborná kniha
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Německo
Utajení
není předmětem státního či obchodního tajemství
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/11:00049897
Organizační jednotka
Lékařská fakulta
ISBN
978-3-8443-8233-4
Klíčová slova anglicky
Sigma Receptor; IP3 receptor; antipsychotics; Haloperidol; Perphenazine; Guinea Pig Heart; rat
Změněno: 4. 1. 2012 12:49, Mgr. Michal Petr
Anotace
V originále
The history of natural as well as medical sciences is full of fascinating stories: some discoveries were caused by mistake and some were actually not firstly perceived as new findings. Discovery and detailed research of sigma receptors belong to such stories undoubtedly. It is a terminated tale - the endogenous ligand was discovered, even if most recently. On the contrary, still some tesseras are missing in this complicated mosaic which such new receptor system represents: it still remains unclear what is their primary role in biological systems and in their regulation. This review is focused on cardiovascular effects of typical representatives of sigma receptor ligands and – at the same time clinically widely used antipsychotics – haloperidol and perphenazine. Use (or even abuse) of various antipsychotics represents worldwide trend within last few decades and thus studies focused on their side effects become a high priority. Moreover, cardiovascular system disorders belong to the most common causes of morbidity and mortality in the developed countries. A significant group of these disorders is represented by side effects of non–cardiovascular drugs.
Návaznosti
| GA102/07/1473, projekt VaV |
| ||
| MSM0021622402, záměr |
|